The probiotics with the strongest evidence for diarrhea depend on what’s causing it. Saccharomyces boulardii, a beneficial yeast, has the most consistent support for preventing diarrhea during antibiotic use. Lactobacillus rhamnosus GG and certain Bifidobacterium strains also show benefits in specific situations, though recent large trials have challenged some earlier findings. No single probiotic works equally well for every type of diarrhea.
How Probiotics Work Against Diarrhea
Probiotics don’t simply “replace” good bacteria. They protect the gut through several overlapping mechanisms. First, they compete with harmful bacteria for nutrients and attachment sites along the intestinal wall, physically blocking pathogens from gaining a foothold. Second, they increase production of mucin, a protein that forms a protective mucus layer over the intestinal lining. This mucus barrier improves nutrient absorption while limiting contact between dangerous bacteria and your gut cells.
Probiotics also produce short-chain fatty acids and organic acids like lactic acid, which lower the pH inside the intestine. Most disease-causing bacteria struggle to survive in acidic environments. On top of that, probiotics strengthen the tight junctions between intestinal cells, essentially sealing the gaps that diarrhea-causing infections try to exploit. They also stimulate the immune system and promote the release of natural antimicrobial compounds in the gut.
Antibiotic-Associated Diarrhea
Antibiotics kill harmful bacteria but also wipe out beneficial species, which is why roughly one in five people develop diarrhea during or shortly after a course of antibiotics. This is where Saccharomyces boulardii has a practical advantage: because it’s a yeast, not a bacterium, antibiotics don’t destroy it. It can function normally even while you’re still taking your prescription.
Earlier meta-analyses suggested S. boulardii could reduce the risk of antibiotic-associated diarrhea by about 60%. However, a rigorous randomized, double-masked trial published in Open Forum Infectious Diseases found no significant difference between S. boulardii (250 mg twice daily) and placebo in hospitalized patients without additional risk factors. The hazard ratio was essentially 1.0, meaning outcomes were identical. This doesn’t mean S. boulardii is useless, but it does suggest the benefits may be limited to higher-risk groups rather than everyone on antibiotics.
Timing matters considerably. A meta-analysis of 19 clinical trials found that starting probiotics within one to two days of beginning antibiotics reduced the risk of C. difficile infection by 68%, compared with a 58% reduction when probiotics were started later. If you’re going to try probiotics alongside antibiotics, beginning them as early as possible appears to be important.
C. difficile Infection Prevention
C. difficile is one of the most dangerous complications of antibiotic use, causing severe, sometimes life-threatening diarrhea. A meta-analysis covering 19 randomized controlled trials and over 6,200 patients found that probiotics cut the risk of C. difficile infection by roughly 50%. The strains studied included S. boulardii, various Lactobacillus species, Bifidobacterium species, and Streptococcus species, used alone or in combination.
The strongest protection appeared in high-risk populations, particularly hospitalized patients on broad-spectrum antibiotics. For people at average risk taking a standard antibiotic course at home, the benefit is less clear.
Acute Gastroenteritis and Stomach Bugs
For years, Lactobacillus rhamnosus GG (often called LGG) was considered the go-to probiotic for acute diarrhea, especially in children. Earlier reviews estimated it could shorten diarrhea episodes by about 13 hours in children with acute illness. A large meta-analysis found that probiotics overall reduced diarrhea duration by roughly half a day in kids, with clinical cure more likely by day seven of treatment.
But a landmark trial published in the New England Journal of Medicine challenged this consensus. In preschool children with acute gastroenteritis, a five-day course of LGG performed no better than placebo. Diarrhea lasted a median of about 50 hours in both groups. Vomiting duration, daycare absenteeism, and household transmission rates were also identical.
For persistent diarrhea in children (lasting 14 days or more), the picture looks different. Probiotics reduced the duration of illness by roughly four days in that subset, though the evidence quality was rated low. In short, probiotics may help more when diarrhea drags on than during a brief stomach bug that resolves on its own.
IBS-Related Diarrhea
Irritable bowel syndrome with diarrhea (IBS-D) is a chronic condition, and the probiotic evidence here points to a specific strain: Bifidobacterium infantis 35624. In a trial of 362 IBS patients, this strain at a dose of 100 million colony-forming units (CFU) per day significantly outperformed placebo for abdominal pain, bloating, bowel dysfunction, incomplete evacuation, straining, and gas after four weeks of use.
Interestingly, higher and lower doses of the same strain didn’t work as well. Only the middle dose (100 million CFU) showed meaningful improvement across the full range of symptoms. This highlights an important principle with probiotics: more isn’t always better, and the effective dose varies by strain.
Traveler’s Diarrhea
Despite widespread marketing, the evidence for probiotics preventing traveler’s diarrhea is weak. The CDC notes that both LGG and S. boulardii have been studied for this purpose, but results are inconclusive. One complicating factor is that standardized preparations of these organisms aren’t reliably available across different countries and brands. The CDC does not currently recommend probiotics for traveler’s diarrhea prevention.
Dosage and What to Look For
The minimum effective dose varies by strain and condition. For LGG in infectious diarrhea, an assessment of 11 trials found it works best at a daily dose of at least 10 billion CFU. For S. boulardii, most studies showing benefit used 1 to 10 billion CFU per day for 5 to 10 days. The B. infantis 35624 strain worked at a much lower count of 100 million CFU daily for IBS symptoms.
When choosing a product, the strain designation matters as much as the species name. Lactobacillus rhamnosus GG is not interchangeable with other Lactobacillus rhamnosus strains. Look for products that list the full strain name and guarantee a specific CFU count through the expiration date, not just at the time of manufacture. Refrigerated products tend to maintain viability better, though some shelf-stable formulations use protective coatings that hold up well at room temperature.
Safety Considerations
For most people, probiotics are well tolerated. The main risks involve people with compromised immune systems, central venous catheters, or severe acute illness. Cases of fungal bloodstream infections have been reported in critically ill patients given S. boulardii, and one trial in patients with severe acute pancreatitis actually found higher mortality in the probiotic group. These are rare scenarios, but they underscore that probiotics are not risk-free for everyone.
Most clinical trials have excluded seriously ill participants, so the safety profile in vulnerable populations remains unclear. If you have a weakened immune system, are hospitalized in intensive care, or have a central IV line, probiotics warrant a conversation with your care team before use. For otherwise healthy people experiencing a bout of diarrhea, the risk of side effects from mainstream probiotic strains is very low.